Assessment of the Clinical Trials Safety Profile of PD-1/PD-L1 Inhibitors Among Patients With Cancer: An Updated Systematic Review and Meta-Analysis

Assessment of the Clinical Trials Safety Profile of PD-1/PD-L1 Inhibitors Among Patients With Cancer: An Updated Systematic Review and Meta-Analysis

BackgroundUnderstanding the safety and adverse event profiles of PD-1/PD-L1 inhibitors is important in guiding cancer immunotherapy. Consequently, we designed this meta-analysis to evaluate the safety of PD-1/PD-L1 inhibitors in clinical trials involving cancer patients.MethodsFour safety indicators...

Full description

Bibliographic Details
Main Authors: Yuan Tian, Alan Huang, Yue Yang, Qi Dang, Qing Wen, Linlin Wang, Yuping Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
PD-1/PD-L1 inhibitors
cancer
meta-analysis
safety assessment
clinical trial
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.662392/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.662392/full

Similar Items